Topchoice Medical Co., Inc. (SHA:600763)
China · Delayed Price · Currency is CNY 35.49
+0.11 (0.31%)
Aug 26, 2026, 3:00 PM CST
Topchoice Medical Co. Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 3,045 | 2,902 | 2,859 | 2,832 | 2,697 | 2,758 |
Other Revenue | 6.21 | 11.29 | 14.6 | 14.51 | 21.21 | 22.23 |
| 3,051 | 2,913 | 2,874 | 2,847 | 2,719 | 2,781 | |
Revenue Growth | 4.78% | 1.37% | 0.96% | 4.70% | -2.23% | 33.18% |
Cost of Revenue | 1,835 | 1,788 | 1,767 | 1,750 | 1,609 | 1,500 |
Gross Profit | 1,216 | 1,125 | 1,107 | 1,097 | 1,110 | 1,281 |
Selling, General & Admin | 363.96 | 354.15 | 348.65 | 338.22 | 312.81 | 283.39 |
Research & Development | 61.28 | 61.23 | 58.95 | 55.65 | 54.03 | 59.13 |
Other Operating Expenses | 1.9 | 4.83 | 4.93 | 6.79 | 6.11 | 7.55 |
Operating Expenses | 438.45 | 431.56 | 415.7 | 402.41 | 374.62 | 351.35 |
Operating Income | 777.79 | 693.72 | 690.92 | 694.35 | 734.97 | 929.37 |
Interest Expense | -17.4 | -35.85 | -45.44 | -55.01 | -50.05 | -28.91 |
Interest & Investment Income | 20.1 | 48.39 | 50.52 | 71.82 | 47.54 | 67.79 |
Other Non Operating Income (Expenses) | -25.6 | -7.67 | -5.3 | -8.37 | -6 | -2.77 |
EBT Excluding Unusual Items | 880.74 | 698.6 | 690.71 | 702.78 | 726.46 | 965.49 |
Gain (Loss) on Sale of Investments | 0.9 | 0.9 | 1.42 | - | - | - |
Gain (Loss) on Sale of Assets | 0.49 | -0.27 | 0.14 | - | -0.05 | -0.02 |
Asset Writedown | -0.36 | -0.36 | -0.86 | -0.42 | -0.51 | -0.21 |
Other Unusual Items | 2 | 6.48 | 2.18 | 6.46 | 12.08 | 9.33 |
Pretax Income | 883.77 | 705.36 | 693.59 | 708.82 | 737.98 | 974.58 |
Income Tax Expense | 154.98 | 117.07 | 121.88 | 130.43 | 122.31 | 188.43 |
Earnings From Continuing Operations | 728.79 | 588.29 | 571.71 | 578.39 | 615.68 | 786.15 |
Minority Interest in Earnings | -89.5 | -86.34 | -70.7 | -77.95 | -67.41 | -83.34 |
Net Income | 639.3 | 501.95 | 501 | 500.44 | 548.27 | 702.81 |
Net Income to Common | 639.3 | 501.95 | 501 | 500.44 | 548.27 | 702.81 |
Net Income Growth | 24.79% | 0.19% | 0.11% | -8.72% | -21.99% | 42.67% |
Shares Outstanding (Basic) | 447 | 447 | 447 | 447 | 449 | 449 |
Shares Outstanding (Diluted) | 447 | 447 | 447 | 447 | 449 | 449 |
Shares Change | 0.23% | -0.01% | 0.11% | -0.50% | -0.09% | 0.32% |
EPS (Basic) | 1.43 | 1.12 | 1.12 | 1.12 | 1.22 | 1.56 |
EPS (Diluted) | 1.43 | 1.12 | 1.12 | 1.12 | 1.22 | 1.56 |
EPS Growth | 24.31% | 0% | 0% | -8.26% | -21.92% | 42.21% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 637.25 | 564.52 | 430.88 | 332.13 | 248.52 | 572.09 |
Free Cash Flow Per Share | 1.43 | 1.26 | 0.96 | 0.74 | 0.55 | 1.27 |
Dividend Per Share | - | - | 0.450 | 0.311 | - | - |
Dividend Growth | - | - | 44.70% | - | - | - |
Gross Margin | 39.87% | 38.63% | 38.51% | 38.53% | 40.81% | 46.06% |
Operating Margin | 25.50% | 23.81% | 24.04% | 24.39% | 27.03% | 33.42% |
Profit Margin | 20.95% | 17.23% | 17.43% | 17.58% | 20.17% | 25.27% |
Free Cash Flow Margin | 20.89% | 19.38% | 14.99% | 11.67% | 9.14% | 20.57% |
EBITDA | 863.24 | 777.12 | 779.56 | 779.55 | 816.57 | 1,001 |
EBITDA Margin | 28.30% | 26.68% | 27.13% | 27.39% | 30.04% | 35.99% |
D&A For EBITDA | 85.45 | 83.4 | 88.63 | 85.21 | 81.6 | 71.43 |
EBIT | 777.79 | 693.72 | 690.92 | 694.35 | 734.97 | 929.37 |
EBIT Margin | 25.50% | 23.81% | 24.04% | 24.39% | 27.03% | 33.42% |
Effective Tax Rate | 17.54% | 16.60% | 17.57% | 18.40% | 16.57% | 19.34% |
Revenue as Reported | 1,465 | 2,913 | 2,874 | 2,847 | 2,719 | 2,781 |
Advertising Expenses | - | 24.91 | 22.93 | 21.54 | 23.41 | 20.87 |